A Phase I, Open-Label, Single Dose, Two-Period, Parallel Group Study Assessing Pharmacokinetics and Safety of Omadacycline in Subjects With Impaired Renal Function and Matched Healthy Subjects
Latest Information Update: 04 May 2020
At a glance
- Drugs Omadacycline (Primary)
- Indications Bacterial infections; Community-acquired pneumonia; Skin and soft tissue infections
- Focus Adverse reactions; Pharmacokinetics
- 27 Apr 2020 Results published in the Antimicrobial Agents and Chemotherapy
- 30 Nov 2017 New trial record
- 20 Nov 2017 Results published in the Antimicrobial Agents and Chemotherapy Journal.